Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus | Zendy

S. Goya Wannamethee | Zendy; A. G. Shaper | Zendy; Lucy Len | Zendy; Richard Morris | Zendy

Open Access

Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus

Author(s) -

S. Goya Wannamethee,

A. G. Shaper,

Lucy Len,

Richard Morris

Publication year - 2005

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.165.22.2644

Subject(s) - metabolic syndrome , medicine , framingham risk score , stroke (engine) , national cholesterol education program , type 2 diabetes mellitus , diabetes mellitus , cardiology , relative risk , confidence interval , framingham heart study , type 2 diabetes , risk factor , disease , endocrinology , obesity , mechanical engineering , engineering

We sought to compare metabolic syndrome (MetS) with the Framingham Risk Score (FRS) as predictors of coronary heart disease (CHD), stroke, and type 2 diabetes mellitus (DM2) in middle-aged men.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research